Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tibolone and climacteric symptoms

L A Ross1, E M Alder

  • 1Department of Management and Social Sciences, Queen Margaret College, Edinburgh, Scotland, UK.

Maturitas
|February 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adding glucose to food and solutions to enhance fructose absorption is not effective in preventing fructose-induced functional gastrointestinal symptoms: randomised controlled trials in patients with fructose malabsorption.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2016
Same author

Pubertal stage and hypoglycaemia counterregulation in type 1 diabetes.

Archives of disease in childhood·2005
Same author

A survey of information given by health professionals, about bottle feeding, to first-time mothers in a Scottish population.

Health bulletin·2003
Same author

What predicts poor collection of medication among children with asthma? A case-control study.

The European respiratory journal·2002
Same author

The RCP's 'Three Key Questions' for asthma: review of practical use.

British journal of community nursing·2002
Same author

Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2001
Same journal

Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices.

Maturitas·2026
Same journal

Mobility limitation trajectories and longitudinal changes in delayed recall in midlife and later life: A multicohort study.

Maturitas·2026
Same journal

Digital twins in menopause: a roadmap for integrating endocrine dynamics, multisystem physiology, and precision medicine.

Maturitas·2026
Same journal

Testosterone therapy in women: Keeping pace with the evidence.

Maturitas·2026
Same journal

Diagnosis and management of androgen excess presenting after menopause.

Maturitas·2026
Same journal

Domain-specific severity of menopausal symptoms and emotional eating in midlife women.

Maturitas·2026
See all related articles

Tibolone is an effective hormone replacement therapy (HRT) for reducing menopausal vasomotor symptoms and vaginal dryness. Further research is needed to clarify its effects on mood and libido.

Area of Science:

  • Reproductive Medicine
  • Endocrinology
  • Women's Health

Background:

  • Hormone replacement therapy (HRT) is used to manage menopausal symptoms.
  • Tibolone offers potential advantages over traditional HRT, including ease of use and absence of withdrawal bleeding.
  • Understanding tibolone's comprehensive effects on postmenopausal women is crucial.

Purpose of the Study:

  • To review the existing evidence on tibolone's efficacy in alleviating climacteric symptoms.
  • To assess the impact of tibolone on vasomotor symptoms, vaginal dryness, mood, and libido.
  • To identify gaps in current research regarding tibolone's non-symptomatic benefits.

Main Methods:

  • Systematic review of published literature on tibolone and menopausal symptom management.

Related Experiment Videos

  • Analysis of studies evaluating tibolone's effects on specific climacteric symptoms.
  • Evaluation of the methodological quality of research concerning mood and libido.

    • Main Results:

    • Tibolone demonstrates significant effectiveness in reducing hot flashes (vasomotor symptoms) and vaginal dryness.
    • Evidence for tibolone's impact on headaches and insomnia remains inconclusive.
    • Existing research on tibolone's effects on mood and libido is often methodologically limited.

    Conclusions:

    • Tibolone is a beneficial HRT option for specific menopausal symptoms like vasomotor complaints and vaginal atrophy.
    • Further methodologically rigorous studies are necessary to definitively establish tibolone's influence on mood and sexual desire.
    • An ongoing study aims to provide clearer insights into tibolone's effects on mood and libido in postmenopausal women.